In his remarks, Kevin Xu emphasized that Professor Xu’s spirit has become the “heart of MEBO,” inspiring continued innovation and global impact. Scholars and longtime associates shared memories and recent advances in regenerative medicine, highlighting sustained progress in both research and clinical practice.

The conference also reviewed MEBO Group’s achievements from 2015 to 2026, showcasing progress in scientific innovation, industrial development, global expansion, and public welfare. In a video message, Li Li noted that true inheritance lies in transforming vision into collective action.

The theme “Legacy, Universality, Resonance” reflects the lasting influence of Professor Xu’s work, whose scientific vision continues to benefit patients worldwide and guide the future of regenerative medicine.

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.